These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


360 related items for PubMed ID: 29557072

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Th17-Inducing Conditions Lead to in vitro Activation of Both Th17 and Th1 Responses in Behcet's Disease.
    Deniz R, Tulunay-Virlan A, Ture Ozdemir F, Unal AU, Ozen G, Alibaz-Oner F, Aydin-Tatli I, Mumcu G, Ergun T, Direskeneli H.
    Immunol Invest; 2017 Jul; 46(5):518-525. PubMed ID: 28414558
    [Abstract] [Full Text] [Related]

  • 3. Expression of Th-17 and RORγt mRNA in Behçet's Disease.
    Hamzaoui K, Bouali E, Ghorbel I, Khanfir M, Houman H, Hamzaoui A.
    Med Sci Monit; 2011 Apr; 17(4):CR227-34. PubMed ID: 21455110
    [Abstract] [Full Text] [Related]

  • 4. Serum IL-33 levels and skin mRNA expression in Behçet's disease.
    Hamzaoui K, Kaabachi W, Fazaa B, Zakraoui L, Mili-Boussen I, Haj-Sassi F.
    Clin Exp Rheumatol; 2013 Apr; 31(3 Suppl 77):6-14. PubMed ID: 23464866
    [Abstract] [Full Text] [Related]

  • 5. Increased serum interleukin-32 levels in patients with Behçet's disease.
    Ha YJ, Park JS, Kang MI, Lee SK, Park YB, Lee SW.
    Int J Rheum Dis; 2018 Dec; 21(12):2167-2174. PubMed ID: 28378461
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Interleukin-26 is overexpressed in Behçet's disease and enhances Th17 related -cytokines.
    Kaabachi W, Bouali E, Berraïes A, Dhifallh IB, Hamdi B, Hamzaoui K, Hamzaoui A.
    Immunol Lett; 2017 Oct; 190():177-184. PubMed ID: 28811236
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Interleukin-28A promotes IFN-γ production by peripheral blood mononuclear cells from patients with Behçet's disease.
    Li B, Xie C, Lin X, Su SB.
    Cell Immunol; 2014 Jul; 290(1):116-9. PubMed ID: 24973639
    [Abstract] [Full Text] [Related]

  • 11. Serum Cytokine Levels in Behçet's Disease.
    Akkurt ZM, Bozkurt M, Uçmak D, Yüksel H, Uçak H, Sula B, Gürsel Özkurt Z, Yildiz M, Akdeniz D, Arica M.
    J Clin Lab Anal; 2015 Jul; 29(4):317-20. PubMed ID: 25130392
    [Abstract] [Full Text] [Related]

  • 12. Vitamin D modulates peripheral immunity in patients with Behçet's disease.
    Hamzaoui K, Ben Dhifallah I, Karray E, Sassi FH, Hamzaoui A.
    Clin Exp Rheumatol; 2010 Jul; 28(4 Suppl 60):S50-7. PubMed ID: 20868571
    [Abstract] [Full Text] [Related]

  • 13. [Analysis of the profile of CD4+ cells in Behçet's disease].
    Sugi N, Nakazawa M, Nakamura S, Minami M, Ohno S.
    Nippon Ganka Gakkai Zasshi; 1997 Apr; 101(4):335-40. PubMed ID: 9136573
    [Abstract] [Full Text] [Related]

  • 14. Serum MMP-2 and MMP-9 in patients with Behçet's disease: do their higher levels correlate to vasculo-Behçet's disease associated with aneurysm formation?
    Pay S, Abbasov T, Erdem H, Musabak U, Simsek I, Pekel A, Akdogan A, Sengul A, Dinc A.
    Clin Exp Rheumatol; 2007 Apr; 25(4 Suppl 45):S70-5. PubMed ID: 17949555
    [Abstract] [Full Text] [Related]

  • 15. IL-22-secreting Th22 and IFN-γ-secreting Th17 cells in Behçet's disease.
    Aktas Cetin E, Cosan F, Cefle A, Deniz G.
    Mod Rheumatol; 2014 Sep; 24(5):802-7. PubMed ID: 24498963
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. IFN-alpha blocks IL-17 production by peripheral blood mononuclear cells in Behcet's disease.
    Liu X, Yang P, Wang C, Li F, Kijlstra A.
    Rheumatology (Oxford); 2011 Feb; 50(2):293-8. PubMed ID: 21059671
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 18.